Distribute the future of Orthopedics
Monogram is actively soliciting interest from independent distributors to represent our products. Learn more about how you can get involved below.
Join us in making this future a reality
Monogram is offering distribution opportunities to a select and limited number of distributors. If you are interested in learning more please email us at ‘firstname.lastname@example.org’.
we are looking for a select number of distributors
10 TOTAL DISTRIBUTORS
To learn more about the requirements to become a Monogram distributor please email us at ‘email@example.com’.
Please contact us to learn more about distribution opportunities and how you can get involved in the Monogram story today!
Monogram’s first target markets will be the hip and knee replacement market which is over $18bn combined.
THE MAJORITY OF THE MARKET IS IMPLANT SALES, WHICH IS WHY MONOGRAM HAS FOCUSED ON INNOVATING THE IMPLANT.
After investing over $225M in 3D printing Styker indicated 100% of their hip cups will be 3D printed. This is getting more efficient than conventional manufacturing. Monogram is developing implants for this future.
“ADDITIVE MANUFACTURING IS THE FUTURE.” KEVIN LOBO, STRYKER CEO
51% of primary hip and knee joint replacement surgeries will be performed in an outpatient setting by 2026. The industry is rapidly shifting to force efficiency on large suppliers. Monogram is built on efficiency.
WE DO NOT BELIEVE HIGH VOLUME HOSPITALS WITH INVENTORY ON CONSIGNMENT IS THE FUTURE
The average implant sits on the shelf for 9.7 months before getting sold. This inefficiency costs the large companies billions of dollars in
Saves $3,000 per surgery on average by reducing the amount of inventory you need on hand.